News
October 2024
We’re growing. You can find us at our new location at 280 Calhoun St. Charleston, SC 29425
September 2024
Dr. HM Lee joined LoxiGen as a Director of research to empower our efforts to optimize the current lead towards an IND application.
August 2024
LoxiGen announced that it successfully completed the Phase I of the Fast-track STTR grant -nearly $2.5M in funding- from the National Institutes of Health (NIH) and moved to the Phase II.
July 2024
The paper describing the lead compound LXG6403 is published in Cell Chemical Biology.
Link: https://www.cell.com/cell-chemical-biology/fulltext/S2451-9456(24)00273-3
April 2024
LoxiGen, Inc. is selected for the highly prestigious Life Science Incubator Program of Innosphere Ventures.
June 2023
The National Cancer Institute has awarded LoxiGen, Inc., a three-year Fast-track Small Business Technology Transfer (STTR) grant to develop LOX inhibitors for drug-resistant TNBC in collaboration with scientists at MUSC and USC.